Affiliation:
1. Shenzhen Technology University
2. Sun Yat-sen University
Abstract
Abstract
Background: Advances in mobile, wearable and machine learning (ML) technologies for gathering and analyzing long-term health data have opened up new possibilities for predicting and preventing cardiovascular diseases (CVDs). Meanwhile, the association between obstructive sleep apnea (OSA) and CV risk has been well-recognized. This study seeks to explore effective strategies of incorporating OSA phenotypic information and overnight physiological information for precise CV risk prediction in the general population.
Methods: 1,874 participants without a history of CVDs from the MESA dataset were included for the 5-year CV risk prediction. Four OSA phenotypes were first identified by the K-mean clustering based on static polysomnographic (PSG) features. Then several phenotype-agnostic and phenotype-specific ML models, along with deep learning (DL) models that integrate deep representations of overnight sleep-event feature sequences, were built for CV risk prediction. Finally, feature importance analysis was conducted by calculating SHapley Additive exPlanations (SHAP) values for all features across the four phenotypes to provide model interpretability.
Results: All ML models showed improved performance after incorporating the OSA phenotypic information. The DL model trained with the proposed phenotype-contrastive training strategy performed the best, achieving an area under the Receiver Operating Characteristic (ROC) curve of 0.877. Moreover, PSG and FOOD FREQUENCY features were recognized as significant CV risk factors across all phenotypes, with each phenotype emphasizing unique features.
Conclusion: Models that are aware of OSA phenotypes are preferred, and lifestyle factors should be a greater focus for precise CV prevention and risk management in the general population.
Publisher
Research Square Platform LLC
Reference50 articles.
1. World Health Organization[EB/OL]. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
2. Diabetes and Cardiovascular Disease: The Framingham Study[J];Kannel WB;JAMA,1979
3. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project[J];Conroy RM;Eur Heart J,2003
4. Mehilli J, Kastrati A, Dirschinger J, et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention[J]. Volume 287. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION; 2002. pp. 210–5. 2.
5. A review of risk prediction models in cardiovascular disease: conventional approach vs. artificial intelligent approach[J];Mohd Faizal AS;Comput Methods Programs Biomed,2021